C07D

Technology



back to "C07D" profile

More Results

Showing 1 to 20 of 101737 results

Patent/Pub #TitleFiling DateIssue/Publication DatePatent Owner
RE49948 Aryl ethers and uses thereofFeb 03, 22Apr 30, 24Peloton Therapeutics, Inc.
RE49931 [1,2,4]triazolo[1,5-a]pyridinyl substituted indole compoundsJan 25, 22Apr 23, 24Bristol-Myers Squibb Company
RE49934 Inhibitors of cellular metabolic processesMar 08, 22Apr 23, 24Servier Pharmaceuticals LLC
RE49918 Cytotoxic benzodiazepine derivativesMay 10, 21Apr 16, 24Immunogen Inc.
RE49893 [1,2,4]triazolo[1,5-a]pyridinyl substituted indole compoundsJan 25, 22Apr 02, 24Bristol Myers Squibb Company
RE49897 Salts of a dihydroquinazoline derivativeMay 14, 21Apr 02, 24AIC246 AG & Co. KG
RE49880 [1,2,4]triazolo[1,5-a]pyridinyl substituted indole compoundsJan 25, 22Mar 26, 24Bristol Myers Squibb Company
RE49873 APP specific bace inhibitors (ASBIs) and uses thereofJul 22, 21Mar 19, 24BUCK INSTITUTE FOR RESEARCH ON AGING
RE49860 Process for preparing (4S)-4-(4-cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-1,4-dihydro-1,6-naphthyridine-3-carboxamide and purification thereof for use as pharmaceutical active ingredientNov 03, 20Mar 05, 24Bayer Pharma Aktiengesellschaft
RE49850 N-(pyridin-2-yl)-4-(thiazol-5-yl)pyrimidin-2-amine derivatives as therapeutic compoundsFeb 02, 22Feb 27, 24AUCENTRA THERAPEUTICS PTY LTD
RE49851 Pyridinylaminopyrimidine derivatives, preparation process and use thereofJul 15, 21Feb 27, 24Shanghai Allist Pharmaceuticals Co., Ltd.
RE49834 Jak1 selective inhibitors and uses thereofNov 15, 21Feb 13, 24Hangzhou Highlightll Pharmaceutical Co., Ltd.
RE49825 Piperidinyl nociceptin receptor compoundsApr 30, 21Feb 06, 24Astraea Therapeutics, LLC
RE49826 Method for the preparation of (4S)-4-(4-cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-1,4-dihydro-1-6-naphthyridine-3-carboxamide and the purification thereof for use as an active pharmaceutical ingredientJul 02, 21Feb 06, 24Bayer Pharma Aktiengesellschaft
RE49811 Sphingosine kinase inhibitorsMar 07, 22Jan 23, 24Apogee Biotechnology Corporation
RE49735 Oxazolidinones as modulators of MGLUR5Sep 22, 21Nov 28, 23Bristol-Myers Squibb Company
RE49700 Substituted nitrogen containing compoundsFeb 23, 21Oct 17, 23Bristol-Myers Squibb Company
RE49699 Inhibitors of TRPC6May 28, 21Oct 17, 23Boehringer Ingelheim International GmbH; Hydra Biosciences, LLC;
RE49698 Substituted dihydroquinazolinesJul 21, 20Oct 17, 23AIC246 AG & Co. KG
RE49687 Thienopyrimidine and thienopyridine compounds and methods of use thereofFeb 02, 21Oct 10, 23The Regents of the University of Michigan; KURA ONCOLOGY, INC.;

Showing 1 to 20 of 101737 results